Large cell/anaplastic medulloblastoma is associated with poor prognosis-a retrospective analysis at a single institute.

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst (2000) 133.74

The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (2007) 49.11

Medulloblastoma comprises four distinct molecular variants. J Clin Oncol (2010) 8.06

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol (2006) 6.92

Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol (2011) 6.67

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol (2016) 6.24

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol (2006) 4.72

Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. Cancer (2002) 3.23

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol (1999) 3.08

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol (2011) 2.82

Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys (2000) 2.33

Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J Clin Oncol (2010) 2.04

Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. J Clin Oncol (2012) 2.01

Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. Eur J Cancer (2009) 1.70

Pediatric medulloblastoma: radiation treatment technique and patterns of failure. Int J Radiat Oncol Biol Phys (1997) 1.62

Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. J Clin Oncol (2010) 1.48

Primary pediatric brain tumors: statistics of Taipei VGH, Taiwan (1975-2004). Cancer (2005) 1.42

Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group Trial 9031. Int J Radiat Oncol Biol Phys (2006) 1.32

"Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group Study. J Neuropathol Exp Neurol (2000) 1.19

Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathol (2016) 1.11

Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas. J Neuropathol Exp Neurol (2003) 1.11

Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma. Acta Neuropathol (2000) 1.11

Large-cell medulloblastomas. A distinct variant with highly aggressive behavior. Am J Surg Pathol (1992) 1.08

Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. Int J Radiat Oncol Biol Phys (2007) 1.08

Recent developments and current concepts in medulloblastoma. Cancer Treat Rev (2013) 1.05

Medulloblastoma: time-dose relationship based on a 30-year review. Int J Radiat Oncol Biol Phys (1998) 1.02

Outcome and prognostic factors of radiation therapy for medulloblastoma. Int J Radiat Oncol Biol Phys (2011) 1.02

Anaplasia and grading in medulloblastomas. Brain Pathol (2003) 1.00

Medulloblastoma: histopathologic and molecular markers of anaplasia and biologic behavior. Acta Neuropathol (2006) 0.87

Cytomorphologic characteristics, differential diagnosis and utility during intraoperative consultation for medulloblastoma. Acta Cytol (2007) 0.80

Management of pediatric and adult patients with medulloblastoma. Curr Treat Options Oncol (2014) 0.80

Factors affecting survival of medulloblastoma in children: the changing concept of management. Childs Nerv Syst (2015) 0.77